JP Stock MarketDetailed Quotes
4565 Nxera Pharma
- 1130
- -36-3.09%
20min DelayTrading Nov 18 13:14 JST
101.59BMarket Cap-12961P/E (Static)
1167High1125Low572.60KVolume1163Open1166Pre Close652.70MTurnover182652wk High0.87%Turnover Ratio89.90MShares112552wk Low-41.19EPS TTM74.60BFloat Cap6545Historical HighLossP/E (Static)66.02MShs Float23Historical Low-87.18EPS LYR3.60%Amplitude--Dividend TTM1.47P/B100Lot Size--Div YieldTTM
Nxera Pharma Key Stats
EPS
According to the latest financial report of Nxera Pharma, the latest earnings per share (TTM) for the company is 13.45. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about Nxera Pharma's free cash flow? The latest report shows it as 1.49B. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Nxera Pharma shows that the company's current ratio is 4.11, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Nxera Pharma, the quick ratio is 3.71, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of Nxera Pharma? The latest ROE figure is -2.11%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Nxera Pharma, the total asset return on investment (ROA) is -0.92%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Nxera Pharma's latest financial report to see how their gross margin is doing - currently at 78.44%.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Nxera Pharma, the net profit margin is 12.95%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data